News
Thermo Fisher Scientific (NYSE:TMO) stock gains as company beats Q2 2025 forecasts with $10.9B revenue, driven by Life Sciences Solutions & Biopharma. Read more here.
Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback